Anselm K. Gitt, MD: DYSIS and Increased Persistent Lipid Abnormalities

At the European Society of Cardiology Congress 2016 (ESC) in Rome, Italy, Anselm Gitt, MD, Vice President, Foundation Institut f., Herzinfarktforschung Ludwigshafen, Germany, discussed the DYSIS program, which was designed to get an idea to see how patients were treated for secondary prevention, focusing on dyslipidemia patients. "We wanted to know if guidelines are applied and patients are put, let's say to their goals, in clinical practice," said Gitt. Their study found an increase in the number of patients being at goal. Studying the differences, Gitt said the main difference was " there was an increased rate of patients treated with potent statins". Gitt concluded that they made people aware they need to bring patients to guidelines, but there's still some way to go to numbers they'd like to see.